Treatment of Residual Myopic Refraction After 6 Months on Pseudophakic Patients Using Relex-Smile

Enrolling by invitation · Not applicable

Conditions studied: Pseudophakia, Myopia

In brief

The aim of this study is to assess visual and refractive outcomes after laser vision correction (LVC) - ReLex Smile to correct residual myopic refraction after 6 months of pseudophakic (IOL) implantation. Before SMILE YAG-Laser capsulotomy should be performed on all patients, regardless of posterior capsule ossification, in pseudophakic patients with residual refraction. When the YAG Laser is applied after the SMILE, there will be a diopter change.

Key facts

Study ID

NCT04693663

Run by

Eye Hospital Pristina Kosovo

People needed

20

Starts

2017-06-01

Expected to finish

2027-06-01

Last updated by the study team

2026-07-29

Who can join

Age: 20 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• residual myopic refraction -0.75d till -5.50D
• complain visual acuity regarding residual myopic refraction

You may not qualify if…

• active anterior segment pathologic features
• previous corneal or anterior segment surgery
• glaucoma
• history of ocular inflammation

Where it is running

• Eye Hospital Pristina — Pristina, Kosovo

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.